Am I mistaken, or is Rizaport now already approved for sale in Germany, with other EU states expected to follow? Or is the "marketing approval" not the last step in bringing a drug to market (I'm not too familiar with the steps required in the EU)?
Otherwise, yes.. many irons in the fire with this small company and I believe some expected triggers (don't recall what off the top of my head) in Q1 or Q2.
News 
Market Data 
Discover 
